sofosbuvir has been researched along with Fibrosis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Hameed, M; Dawood, RM; El Ray, AA; Mahmoud Diab, T; Mashaal, AR; Seyam, M; Shemis, MA | 1 |
| Chiang, KM; El Moustaid, F; Kaushik, A; Nyberg, AH; Nyberg, LM; Smith, N; Yang, SJ; Yehoshua, A | 1 |
| Burman, B; Edwards, AM; Kozarek, RA; Lee, H; Shin, HP; Siddique, A; Wang, C; Zehr, T; Zeigler, A | 1 |
| Allegre, T; Alric, L; Amri, I; Aumaitre, H; Bailly, F; Bellissant, E; Billaud, E; Bourlière, M; Carrieri, MP; Chas, J; Chevaliez, S; Cotte, L; De Truchis, P; Dominguez, S; Dupon, M; Fougerou-Leurent, C; Garraffo, R; Girard, PM; Jeantils, V; Lacombe, K; Leroy, V; Marcellin, F; Metivier, S; Molina, JM; Morlat, P; Naqvi, A; Neau, D; Pabic, EL; Pageaux, GP; Pailhé, A; Perré, P; Piroth, L; Poizot-Martin, I; Pol, S; Raffi, F; Renault, A; Reynes, J; Rosenthal, E; Salmon-Ceron, D; Teicher, E; Tual, C; Valantin, MA; Yazdanpanah, Y; Zucman, D | 1 |
| El-Raziky, M; Elsharkawy, A; Fouad, A; Khairy, M; Salama, A; Tantawy, O | 1 |
| Brøckner Siggard, C; Chayama, K; Damgaard Sandahl, T; Douglas, MW; George, J; Grønbaek, H; Hagelskjaer Kristensen, L; Hiramatsu, A; Kazankov, K; Lund Laursen, A; Lund Laursen, T; Møller, HJ; Nakahara, T; Ong, A; Tarp, B | 1 |
| Bahra, M; Blaeker, H; Dürr, M; Eurich, D; Eurich, F; Globke, B; Maurer, MM; Pratschke, J; Teegen, EM; Vollbort, A | 1 |
| Avalos, D; Bhamidimarri, KR; Carrion, AF; Gutierrez, JA; Martin, P; O'Brien, C; Peyton, A | 1 |
| Beinhardt, S; Ferenci, P; Hofer, H; Peck-Radosavljevic, M | 1 |
| Aljudaibi, B; Bilodeau, M; Congly, SE; Cooper, C; Faisal, N; Ghali, MP; Hirsch, G; Hussaini, T; Leonard, J; Lilly, LB; Ma, MM; Peltekian, K; Renner, EL; Yoshida, EM | 1 |
| Johnson, S; Marx, SE; Misurski, D; Parisé, H; Saab, S; Sanchez Gonzalez, Y; Virabhak, S; Wang, A | 1 |
| AbdAllah, M; Abdo, M; Alem, SA; Bourliere, M; El Akel, W; El Raziky, M; Elsharkawy, A; Esmat, G; Fouad, R; Tantawi, O | 1 |
1 review(s) available for sofosbuvir and Fibrosis
| Article | Year |
|---|---|
Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cholestasis, Intrahepatic; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Lactams, Macrocyclic; Liver Cirrhosis; Liver Transplantation; Macrocyclic Compounds; Proline; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Valine | 2015 |
1 trial(s) available for sofosbuvir and Fibrosis
| Article | Year |
|---|---|
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
Topics: Aged; Benzimidazoles; Coinfection; Drug Administration Schedule; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Patient Reported Outcome Measures; Pilot Projects; Sofosbuvir; Sustained Virologic Response; Treatment Outcome | 2018 |
10 other study(ies) available for sofosbuvir and Fibrosis
| Article | Year |
|---|---|
Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
Topics: Aged; alpha-Fetoproteins; Antiviral Agents; Carbamates; Cross-Sectional Studies; Drug Therapy, Combination; Egypt; Fibrosis; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Leukocytes, Mononuclear; Pyrrolidines; Ribavirin; RNA; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2022 |
Real-world value of direct-acting antivirals for hepatitis C at Kaiser Permanente Southern California.
Topics: Antiviral Agents; California; Drug Therapy, Combination; Fibrosis; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Middle Aged; Sofosbuvir | 2023 |
Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate | 2017 |
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.
Topics: Antiviral Agents; Female; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Microbial Sensitivity Tests; Middle Aged; Ribavirin; Sofosbuvir | 2018 |
Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Cross-Sectional Studies; Female; Fibrosis; Hepatitis C, Chronic; Humans; Internationality; Liver; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prospective Studies; Receptors, Cell Surface; ROC Curve; Sofosbuvir; Sustained Virologic Response | 2018 |
Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence.
Topics: Aged; Aged, 80 and over; Allografts; Antiviral Agents; Biopsy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; End Stage Liver Disease; Female; Fibrosis; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Sofosbuvir; Sustained Virologic Response | 2019 |
Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients.
Topics: Aged; Allografts; Antiviral Agents; Drug Therapy, Combination; Female; Fibrosis; Genotype; Hepacivirus; Hepatitis C; Humans; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Simeprevir; Sofosbuvir | 2015 |
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
Topics: Aged; Antiviral Agents; Biopsy; Canada; Creatinine; Female; Fibrosis; Genotype; Glomerular Filtration Rate; Hepatitis C; Humans; Interferons; Kidney; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir | 2016 |
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Markov Chains; Middle Aged; Models, Econometric; Proline; Quality-Adjusted Life Years; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Valine | 2016 |
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.
Topics: Adult; Antiviral Agents; Elasticity Imaging Techniques; Female; Fibrosis; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Regression Analysis; Retrospective Studies; Sofosbuvir; Treatment Outcome | 2017 |